| HGNC Family | Sulfatases (ARS) |
| Name | sulfatase 2 |
| Description | Heparan sulfate proteoglycans (HSPGs) act as coreceptors for numerous heparin-binding growth factors and cytokines and are involved in cell signaling. Heparan sulfate 6-O-endosulfatases, such as SULF2, selectively remove 6-O-sulfate groups from heparan sulfate. This activity modulates the effects of heparan sulfate by altering binding sites for signaling molecules (Dai et al., 2005 [PubMed 16192265]).[supplied by OMIM, Mar 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSULF2 is an extracellular endosulfatase that is synthesized as a prepro‐enzyme, undergoes proteolytic processing in the secretory pathway, and is subsequently released into the extracellular milieu. It catalyzes the removal of 6‑O‑sulfate groups from glucosamine residues within heparan sulfate (HS) chains, thereby editing the sulfation pattern of HS proteoglycans. Such precise desulfation determines the binding affinity of HS for a variety of growth factors and morphogens, and detailed biochemical analyses have revealed that SULF2 functions at a near‐neutral pH with a substrate–restricted, processive mechanism that is essential to modulate HS–ligand interactions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of cancer, aberrant regulation of SULF2 contributes to tumor progression by reshaping the extracellular HS landscape and consequently modulating several growth factor–dependent signaling pathways. Up‑regulation of SULF2 has been reported in a variety of malignancies—including breast, lung, hepatocellular, and glioblastoma—where its enzymatic activity diminishes HS 6‑O‑sulfation and thereby enhances the bioavailability and signaling of ligands such as fibroblast growth factors, Wnts, and vascular endothelial growth factor. This deregulated signaling stimulates oncogenic cascades (including Akt, MAPK, and Wnt/β‑catenin pathways), promoting cell proliferation, invasiveness, angiogenesis, altered cell adhesion, and resistance to chemotherapeutic agents. Conversely, experimental inhibition or knockdown of SULF2 reverses such transformed phenotypes, underscoring its potential as a therapeutic target."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "29"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its prominent role in cancer, SULF2 also participates in diverse physiological and pathological processes by finely tuning extracellular matrix signaling. Altered SULF2 expression has been linked to changes in cartilage glycosaminoglycan sulfation, which can affect tissue remodeling, while in the nervous system its activity modulates axon guidance through the regulation of repellent cues. Additionally, SULF2 influences inflammatory responses—for example, by modulating cytokine signaling in rheumatoid arthritis—and can impact the cellular response to stressors such as ionizing radiation, thereby affecting tumor cell invasion and metastasis. Recent studies also implicate SULF2 in mediating epithelial–mesenchymal transition via microRNA pathways, as well as in determining the aggressiveness of neoplasms such as neuroblastoma, cholangiocarcinoma, and glioblastoma. Collectively, these observations emphasize the multifaceted impact of SULF2 on key signaling events in both normal tissue homeostasis and disease, highlighting its emerging potential as a biomarker and a therapeutic target."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "30", "end_ref": "44"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Megumi Morimoto-Tomita, Kenji Uchimura, Zena Werb, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M205131200"}], "href": "https://doi.org/10.1074/jbc.M205131200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12368295"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12368295"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Kenji Uchimura, Megumi Morimoto-Tomita, Annette Bistrup, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Biochem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2091-7-2"}], "href": "https://doi.org/10.1186/1471-2091-7-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16417632"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16417632"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "William C Lamanna, Marc-André Frese, Martina Balleininger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M802130200"}], "href": "https://doi.org/10.1074/jbc.M802130200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18687675"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18687675"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Renhong Tang, Steven D Rosen "}, {"type": "b", "children": [{"type": "t", "text": "Functional consequences of the subdomain organization of the sulfs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.028472"}], "href": "https://doi.org/10.1074/jbc.M109.028472"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19520866"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19520866"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Amal Seffouh, Fabian Milz, Cédric Przybylski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HSulf sulfatases catalyze processive and oriented 6-O-desulfation of heparan sulfate that differentially regulates fibroblast growth factor activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.12-226373"}], "href": "https://doi.org/10.1096/fj.12-226373"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23457216"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23457216"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yuemeng Dai, Yang Yang, Veronica MacLeod, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M508136200"}], "href": "https://doi.org/10.1074/jbc.M508136200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16192265"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16192265"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Megumi Morimoto-Tomita, Kenji Uchimura, Annette Bistrup, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1593/neo.05496"}], "href": "https://doi.org/10.1593/neo.05496"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16331886"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16331886"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "H Lemjabbar-Alaoui, A van Zante, M S Singer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2009.365"}], "href": "https://doi.org/10.1038/onc.2009.365"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19855436"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19855436"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Sarah M Peterson, Andrea Iskenderian, Lynette Cook, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenografts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-10-427"}], "href": "https://doi.org/10.1186/1471-2407-10-427"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20707913"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20707913"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jin-Ping Lai, Abdul M Oseini, Catherine D Moser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.23848"}], "href": "https://doi.org/10.1002/hep.23848"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20725905"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20725905"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Jin-Ping Lai, Dalbir S Sandhu, Chunrong Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Liver Int (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1478-3231.2010.02336.x"}], "href": "https://doi.org/10.1111/j.1478-3231.2010.02336.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21040406"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21040406"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Gregory O Staples, Xiaofeng Shi, Joseph Zaia "}, {"type": "b", "children": [{"type": "t", "text": "Glycomics analysis of mammalian heparan sulfates modified by the human extracellular sulfatase HSulf2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0016689"}], "href": "https://doi.org/10.1371/journal.pone.0016689"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21347431"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21347431"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Caroline Bret, Jérôme Moreaux, Jean-François Schved, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SULFs in human neoplasia: implication as progression and prognosis factors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1479-5876-9-72"}], "href": "https://doi.org/10.1186/1479-5876-9-72"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21599997"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21599997"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Rai B S Gill, Amy Day, Amy Barstow, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulf2 gene is alternatively spliced in mammalian developing and tumour tissues with functional implications."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2011.09.088"}], "href": "https://doi.org/10.1016/j.bbrc.2011.09.088"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21968018"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21968018"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "M Tessema, C M Yingling, C L Thomas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.577"}], "href": "https://doi.org/10.1038/onc.2011.577"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22158045"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22158045"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Joanna J Phillips, Emmanuelle Huillard, Aaron E Robinson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI58215"}], "href": "https://doi.org/10.1172/JCI58215"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22293178"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22293178"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Ashwani Khurana, Hiedi McKean, Hyunseok Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/bcr3140"}], "href": "https://doi.org/10.1186/bcr3140"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22410125"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22410125"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Niina Matikainen, Maria Antonella Burza, Stefano Romeo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0079473"}], "href": "https://doi.org/10.1371/journal.pone.0079473"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24278138"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24278138"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "H Carlijne Hassing, R Preethi Surendran, Bruno Derudas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Obesity (Silver Spring) (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/oby.20682"}], "href": "https://doi.org/10.1002/oby.20682"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24339435"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24339435"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Lin Wang, Li Xie, Jun Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlation between the methylation of SULF2 and WRN promoter and the irinotecan chemosensitivity in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Gastroenterol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-230X-13-173"}], "href": "https://doi.org/10.1186/1471-230X-13-173"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24359226"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24359226"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Roop M S Gill, Andreas Michael, Leah Westley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2014.04.001"}], "href": "https://doi.org/10.1016/j.yexcr.2014.04.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24726914"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24726914"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Mark S Singer, Joanna J Phillips, Hassan Lemjabbar-Alaoui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SULF2, a heparan sulfate endosulfatase, is present in the blood of healthy individuals and increases in cirrhosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Chim Acta (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cca.2014.10.038"}], "href": "https://doi.org/10.1016/j.cca.2014.10.038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25444749"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25444749"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Carolina M Vicente, Marcelo A Lima, Edwin A Yates, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enhanced tumorigenic potential of colorectal cancer cells by extracellular sulfatases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-14-0372"}], "href": "https://doi.org/10.1158/1541-7786.MCR-14-0372"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25477293"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25477293"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Carolina M Vicente, Marcelo A Lima, Helena B Nader, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-015-0141-x"}], "href": "https://doi.org/10.1186/s13046-015-0141-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25887999"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25887999"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Chenfang Zhu, Liu He, Xin Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2015.4525"}], "href": "https://doi.org/10.3892/or.2015.4525"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26708018"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26708018"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Natalie S Lui, Yi-Wei Yang, Annemieke van Zante, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0148911"}], "href": "https://doi.org/10.1371/journal.pone.0148911"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26882224"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26882224"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Sarah A Flowers, Xin Zhou, Jing Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9506"}], "href": "https://doi.org/10.18632/oncotarget.9506"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27223083"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27223083"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Youmao Tao, Tao Han, Tao Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2017.03.017"}], "href": "https://doi.org/10.1016/j.biopha.2017.03.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28320104"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28320104"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Sarah Yoon, Eun-Ju Lee, Ji-Hye Choi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-018-0291-3"}], "href": "https://doi.org/10.1038/s41388-018-0291-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29720727"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29720727"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Shuhei Otsuki, Noboru Taniguchi, Shawn P Grogan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and osteoarthritic articular cartilage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Res Ther (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/ar2432"}], "href": "https://doi.org/10.1186/ar2432"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18507859"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18507859"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Takuya Okada, Kazuko Keino-Masu, Satoshi Nagamine, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Desulfation of Heparan Sulfate by Sulf1 and Sulf2 Is Required for Corticospinal Tract Formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-14185-3"}], "href": "https://doi.org/10.1038/s41598-017-14185-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29062064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29062064"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Wei Huo, Xiao-Min Zhu, Xin-Yan Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Math Biosci Eng (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3934/mbe.2019231"}], "href": "https://doi.org/10.3934/mbe.2019231"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31499680"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31499680"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Ruby J Siegel, Anil K Singh, Paul M Panipinto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Extracellular sulfatase-2 is overexpressed in rheumatoid arthritis and mediates the TNF-α-induced inflammatory activation of synovial fibroblasts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Immunol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41423-022-00913-x"}], "href": "https://doi.org/10.1038/s41423-022-00913-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36068294"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36068294"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Chan-Hun Jung, Jin-Nyoung Ho, Jong Kuk Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of SULF2 in y-irradiation-induced invasion and resistance of cancer cells by inducing IL-6 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.7449"}], "href": "https://doi.org/10.18632/oncotarget.7449"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26895473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26895473"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Shin Kumagai, Kei Ishibashi, Masao Kataoka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.13074"}], "href": "https://doi.org/10.1111/cas.13074"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27589337"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27589337"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Sari F Alhasan, Beate Haugk, Laura F Ogle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2016.264"}], "href": "https://doi.org/10.1038/bjc.2016.264"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27560551"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27560551"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Kurtis Graham, Joshua I Murphy, Gurtej K Dhoot "}, {"type": "b", "children": [{"type": "t", "text": "SULF1/SULF2 reactivation during liver damage and tumour growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histochem Cell Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00418-016-1425-8"}], "href": "https://doi.org/10.1007/s00418-016-1425-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27013228"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27013228"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Roop Ms Gill, Vedika Mehra, Emma Milford, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Short SULF1/SULF2 splice variants predominate in mammary tumours with a potential to facilitate receptor tyrosine kinase-mediated cell signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histochem Cell Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00418-016-1454-3"}], "href": "https://doi.org/10.1007/s00418-016-1454-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27294358"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27294358"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Jie Shen, Jia Wei, Hao Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SULF2 methylation is associated with in vitro cisplatin sensitivity and clinical efficacy for gastric cancer patients treated with a modified FOLFOX regimen."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0075564"}], "href": "https://doi.org/10.1371/journal.pone.0075564"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24124496"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24124496"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Valeria Solari, Lucia Borriello, Gianluca Turcatel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-13-2513"}], "href": "https://doi.org/10.1158/0008-5472.CAN-13-2513"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25164011"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25164011"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Xin Luo, Nellie A Campbell, Li He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2-Platelet-Derived Growth Factor Receptor Beta-Yes-Associated Protein Signaling Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.31817"}], "href": "https://doi.org/10.1002/hep.31817"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33735525"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33735525"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Yue Yu, Hao Li, Yucai Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluating Tumor-Associated Activity of Extracellular Sulfatase by Analyzing Naturally Occurring Substrate in Tumor Microenvironment of Hepatocellular Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Anal Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/acs.analchem.6b03469"}], "href": "https://doi.org/10.1021/acs.analchem.6b03469"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28193024"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28193024"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "J H Kim, C Chan, C Elwell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Microbiol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cmi.12133"}], "href": "https://doi.org/10.1111/cmi.12133"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23480519"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23480519"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Anna Wade, Jane R Engler, Vy M Tran, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Measuring sulfatase expression and invasion in glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Methods Mol Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/978-1-4939-1714-3_39"}], "href": "https://doi.org/10.1007/978-1-4939-1714-3_39"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25325976"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25325976"}]}]}]}
|
| Synonyms | HSULF-2 |
| Proteins | SULF2_HUMAN |
| NCBI Gene ID | 55959 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SULF2 has 8,288 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 112 datasets.
Click the + buttons to view associations for SULF2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SULF2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SULF2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SULF2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SULF2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SULF2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SULF2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SULF2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SULF2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SULF2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SULF2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene Mutation Profiles | cell lines with SULF2 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with SULF2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SULF2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SULF2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SULF2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SULF2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SULF2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SULF2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SULF2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SULF2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SULF2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SULF2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SULF2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SULF2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with SULF2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of SULF2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SULF2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with SULF2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SULF2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SULF2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SULF2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SULF2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SULF2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SULF2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SULF2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SULF2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with SULF2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with SULF2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SULF2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SULF2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SULF2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SULF2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SULF2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SULF2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SULF2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SULF2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding SULF2 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SULF2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SULF2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SULF2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SULF2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SULF2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SULF2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SULF2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SULF2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SULF2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SULF2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SULF2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with SULF2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SULF2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SULF2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SULF2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SULF2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for SULF2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SULF2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SULF2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SULF2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SULF2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with SULF2 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SULF2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SULF2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SULF2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SULF2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SULF2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Kinase Library Tyrosine Kinome Atlas | kinases that phosphorylate SULF2 protein from the Kinase Library Tyrosine Kinome Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SULF2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of SULF2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SULF2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SULF2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing SULF2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SULF2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SULF2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SULF2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SULF2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SULF2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SULF2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SULF2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SULF2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing SULF2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SULF2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SULF2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SULF2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SULF2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SULF2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of SULF2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SULF2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SULF2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SULF2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SULF2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with SULF2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of SULF2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of SULF2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of SULF2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SULF2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SULF2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SULF2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SULF2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SULF2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SULF2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SULF2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SULF2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SULF2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |